- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
GC Genome Corp (340450)
Track today's live GC Genome (340450) share price, performance and key data on this page with our current KOSDAQ:340450 stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the GC Genome share price on the KOSDAQ exchange. Use the dropdown to switch exchange for the 340450 share price, head to our technical summary section, which provides analysis on GC Genome share price buy/sell indicators using real-time data (or discuss the GC Genome (340450) stock price today with other investors in the GC Genome KQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current KQ:340450 share price (ISIN: KR7340450006) to enhance your trading decisions with our free investment tools and resources.
What Is the GC Genome Corp Share Price Today?
The GC Genome share price today is 4,730.
What Is the Stock Symbol for GC Genome Corp
The stock symbol (or 'ticker') for GC Genome Corp is "340450."
What Stock Exchange Does GC Genome Corp Trade On?
GC Genome Corp is listed and trades on the KOSDAQ stock exchange.
Is GC Genome Corp a Good Stock to Buy?
Determining whether GC Genome (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current KQ:340450 share price (ISIN: KR7340450006) to enhance your trading decisions with our free investment tools and resources.
What Is the GC Genome Corp Share Price Today?
The GC Genome share price today is 4,730.
What Is the Stock Symbol for GC Genome Corp
The stock symbol (or 'ticker') for GC Genome Corp is "340450."
What Stock Exchange Does GC Genome Corp Trade On?
GC Genome Corp is listed and trades on the KOSDAQ stock exchange.
Is GC Genome Corp a Good Stock to Buy?
Determining whether GC Genome (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
KOSDAQ
Currency in KRW
4,730
+110(+2.38%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4,490
4,750
52 wk Range
4,225
9,520
340450 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4,4904,750
52 wk Range
4,2259,520
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
340450 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Prominent player in the Biotechnology industry
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Earnings
Latest Release
15/05/2026
EPS / Forecast
34.00 / --
Revenue / Forecast
7.44B / --
Compare 340450 to Peers and Sector
Metrics to compare | 340450 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship340450PeersSector | |
|---|---|---|---|---|
P/E Ratio | 24.5x | −6.5x | −0.4x | |
PEG Ratio | 0.02 | −0.16 | 0.00 | |
Price/Book | 1.4x | 1.7x | 2.6x | |
Price / LTM Sales | 3.5x | 5.7x | 3.1x | |
Upside (Analyst Target) | - | 83.4% | 50.8% | |
Fair Value Upside | Unlock | 17.4% | 7.8% | Unlock |
GC Genome Corporation operates as a clinical genome analysis company in South Korea. It offers hereditary cancer, tissue and liquid biopsy genetic, blood cancer, and homologous recombination deficiency tests under the Green Plan names; Guardant360, a blood genetic profiling test; Guardant Reveal, a liquid biopsy microscopic residual disease detection and recurrence monitoring test; and genetic rare disease testing services for chromosomal microarray, targeted exome sequencing, whole exome sequencing, and diagnostic genome sequencing. The company also provides ai-CANCERCH, an AI algorithm-based multi-cancer early screening test; Jins Sketch, a genetic test for personalized nutrition; Genome Health and Risk Screen that identifies various disease-susceptibility genes; Green Biome for human symbiotic microorganism genetic analysis service; Genome Screen, an optimal genetic test for preemptive action; Telorisk, an indicator of biological age; and drug compatibility DNA test. In addition, it offers G-NIPT, a noninvasive fetal chromosomal abnormality screening test; Prenatal CMA, a diagnostic test for fetal chromosomal abnormalities with higher diagnostic value; i-screen for newborn genetic screening; and dd-cfDNA, a single nucleotide polymorphism test of cell-free nucleic acid derived from organ transplant donors. The company was founded in 2013 and is based in Yongin-si, South Korea.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the GC Genome (KOSDAQ: 340450) Share Price Today?
The GC Genome stock price today is 4,730 KRW.
What Stock Exchange Does GC Genome (340450) Trade On?
GC Genome is listed and trades on the KOSDAQ.
What Is the Ticker (Stock Symbol) for GC Genome?
The stock symbol (also called a 'ticker') for GC Genome is "340450."
What Is the Current GC Genome Market Capitalisation?
As of today, GC Genome (KOSDAQ: 340450) market cap is 111.87B KRW.
What Is GC Genome's (340450) Earnings Per Share (TTM)?
The GC Genome EPS is currently 199 (Trailing Twelve Months).
Is 340450 a Buy or Sell From a Technical Analyst Perspective?
Based on today's GC Genome moving averages and other technical indicators, the daily buy/sell signal for 340450 stock is Neutral.
How Many Times Has GC Genome Stock Split?
GC Genome has split 0 times. (See the 340450 stock split history page for full effective split date and price information.)
What is the current trading status of GC Genome (KOSDAQ: 340450)?
As of 17/07/2026, GC Genome (340450) is trading at a share price of 4,730 KRW, with a previous close of 4,620 KRW. The stock has fluctuated within a day range of 4,490 KRW to 4,750 KRW, while its 52-week range spans from 4,225 KRW to 9,520 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.